Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic response to norepinephrine in septic shock among cirrhotic versus non-cirrhotic critically ill adults
TCTR20251108003Active, not recruiting
- Sponsor
- N/A
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of norepinephrine in septic shock and sepsis (2 cohorts), sponsored by N/A. Primary endpoint: Time to achieve MAP 65 mm Hg after norepinephrine initiation. Started Oct 2025; status: active, not recruiting.
02
Drugs
norepinephrine
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on TCTR20251108003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251108003.